News

Article

Yale researchers identify corneal ulcer pathogens by testing tears

Fact checked by:

Key Takeaways

  • Yale researchers developed a noninvasive diagnostic method for bacterial corneal ulcers using nanopore-based DNA sequencing on tear samples.
  • The new method bypasses invasive corneal scraping, offering faster and potentially more accurate results than traditional culturing.
SHOW MORE

A new study demonstrates that handheld nanopore sequencers can rapidly identify eye infection pathogens using only a patient’s tears.

(Image credit: AdobeStock/Vitalii Vodolazskyi)

Using real-time DNA sequencing, scientists can now detect bacterial pathogens in corneal ulcers without the need for traditional corneal scraping. (Image credit: AdobeStock/Vitalii Vodolazskyi)

Researchers at Yale School of Medicine have identified in a new study a novel, noninvasive method for diagnosing bacterial corneal ulcers, a serious ophthalmologic condition that can lead to vision loss.1

Corneal ulcers, primarily caused by microbial keratitis, represent a global health challenge, contributing to up to 2 million cases of blindness annually. Current diagnostic methods rely on corneal scraping and culturing, which are invasive, time-consuming, and often yield false-negative results.1

“This work has the potential to redefine the diagnostic standard of care for corneal ulcers,” said Mathieu Bakhoum, MD, PhD, assistant professor of ophthalmology and visual science and senior author of the study. “Timely and targeted treatment prevents ulcer progression, reduces broad-spectrum antibiotic use, and diminishes the downstream need for surgical interventions.”

In a study published in Translational Vision Science and Technology, the Yale team used samples from 10 patients with bacterial corneal ulcers to compare traditional scrape-based culture diagnostics with nanopore-based DNA sequencing performed on tear samples using Oxford Nanopore Technologies’ portable MinION sequencer.1

“We were able to show that we can amplify the 16S rRNA bacterial gene directly from tears—bypassing both corneal scraping and nucleic-acid extraction—and obtain real-time, species-level identification using a handheld sequencer,” Backhoum said.

Researchers report the nanopore sequencing matched traditional cultures in all cases where the culture identified bacterial pathogens, and even detected bacteria in 2 cases where cultures were inconclusive. The Yale team said the sequencing of tears provided results in hours, compared with days for traditional culture-based methods.

Further research is needed to validate the technique across diverse pathogens and populations. Researchers said faster turnaround times in corneal ulcer diagnosis could reduce delays in treatment and result in better outcomes and less vision loss worldwide.

The research was supported by a grant from the Connecticut Lions Eye Research Foundation.

Reference
  1. Dibbs M, Matesva M, Theotoka D, et al. A tear-based approach for rapid identification of bacterial pathogens in corneal ulcers using nanopore sequencing. Transl Vis Sci Technol. 2025;14(4):19. doi:10.1167/tvst.14.4.19

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.